Institutional investors hold a majority ownership of BMY through the 72.89% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended September 2014, these large investors purchased a net $20.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PRINCIPAL MANAGEMENT CORP. Bought 949.7 Thousand shares of Bristol-Myers Squibb
CULLINAN ASSOCIATES, INC. Bought 323.0 Thousand shares of Bristol-Myers Squibb